BioSpace News Archive

University of Colorado Anschutz Medical Campus, Chancellor Discovery Innovation Fund (CDI Fund) Finalizes Investment in Summit Biolabs

GoMeyra, an innovative new software company dedicated to providing revolutionary tech solutions for medical laboratories, announces its roster of national labs and medical practice clients now utilizing the proprietary system, GoMeyra LIMS.

Melmark is pleased to announce the receipt of a $21.5 million endowment gift from the Anne and Brutus Kenan fund to further secure the not-for-profit organization’s mission well into the future. Melmark provides clinically-

Bosley is with you every step of the way: Easy, convenient and confidential, this service discretely delivers hair loss treatments right to your doorstep

Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address patients’ unmet needs and solve therapeutic problems, announced today the completion of a Type A meeting with the U.S. Food and Drug Administration (FDA) confirming a pathway for resubmission for approval of the Company’s drug candidate Libervant

Tivity Health, Inc. (NASDAQ: TVTY) today announced that it will present at the following virtual investor conferences:

Industrial microbiology refers to a branch of applied microbiology that is used in various industrial processes.

The growing prevalence of infectious diseases across the world and the alarming need to control them may invite tremendous growth prospects for the preventable vaccines market across the assessment period of 2020-2030.

The demand in the global allergy treatment market is projected to increment at a healthy CAGR of 5.5% during the forecast period of 2017 to 2025, gaining traction from a number of factors such as presence of vast unmet medical needs in various emerging economies, growing prevalence of asthma and allergic rhinitis along with high consumption of tobacco, various novel molecules in pipeline, and upsurge in allergies as a result of environmental pollution.

Startup Receives US$150K Grand Prize for development of an accurate, affordable, and globally scalable early cancer detection from small, 10mL blood samples